Early dose management and up-titration of esketamine in the double-blind induction phase of the randomized, active-controlled, phase 3 TRANSFORM-2 study

Neuroscience Applied 2026 Open access

Read full text

Authors: Patricio Molero, T. Caraballo Lopez, A. Lignugaris, D.J. Fu, C. Bossie

DOI: 10.1016/j.nsa.2025.105657

Cited by: 0

Fields of Study & Subjects

Treatment of Major Depression Neurotransmitter Receptor Influence on Behavior Neurological disorders and treatments